On the Road to New Medicines For most of the 20th century, we discovered new drugs by trial and error. Scientists investigated countless unrelated compounds in animals to see which improved disease symptoms. For instance, in the 1950s and 60s, British scientists at...
From The Lab To The Patient In this issue of the Biotech Primer WEEKLY we will recap the past seven issues that highlight the journey a molecule takes from the lab to the patient. Beginning in the 1980’s, scientists took a new tack in developing drugs. They...
PERSONAL GENOMICS TURNS HEADS IN BIOTECH 23andMe, the Silicon Valley based personal genomics company named for the 23 pairs of chromosomes in a normal human cell, is turning a few heads in the biotechnology industry lately. After a very public and still unresolved...
Osteoporosis is the loss of bone density which causes bones to become weak, brittle, and easily broken. In healthy people, bone is constantly being broken down and replaced. When bone is broken down more quickly than it is replaced, osteoporosis occurs. As the disease...
Last week, we examined cell lines—what they are, where they come from, and how companies use them in the discovery phase of drug development. This week, we turn to the critical role of cell lines in making those drugs. Although all drugs restore or improve our health,...
From startups to the Fortune 500, we train employees at companies of all sizes. We offer customized, in-house courses and open enrollment classes. Visit Biotech Primer for more information.
